Neurogene (NGNE) Current Assets (2013 - 2026)

Neurogene's Current Assets history runs 14 years deep, the most recent figure standing at $246.7 million for Q1 2026.

• Quarterly Current Assets fell 16.75% year-over-year to $246.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246.7 million (down 16.75% YoY) and the FY2025 annual result came in at $271.8 million, down 13.98% from the prior year.
• Current Assets was $246.7 million for Q1 2026 at Neurogene, down from $271.8 million in the prior quarter.
• Across five years, Current Assets topped out at $315.9 million in Q4 2024 and bottomed at $79.9 million in Q3 2023.
• A 5-year average of $179.4 million and a median of $159.1 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets plunged 41.16% — and 2023, when it jumped 136.49%.
• Neurogene's Current Assets stood at $84.7 million in 2022, then soared by 136.49% to $200.3 million in 2023, then surged by 57.69% to $315.9 million in 2024, then decreased by 13.98% to $271.8 million in 2025, then fell by 9.21% to $246.7 million in 2026.
• Business Quant data shows NGNE's Current Assets at $246.7 million in Q1 2026, $271.8 million in Q4 2025, and $270.5 million in Q3 2025.